Joe Rogan Joins Trump for Signing of EO to Fast-Track Access to Psychedelic Drug-Based Research, Treatment

mental-health

Podcaster Joe Rogan joined President Donald Trump in the Oval Office for the signing of an executive order to fast-track access to medical research and treatments based on psychedelic drugs. Trump announced “historic reforms to dramatically accelerate access to new medical research and treatments based on psychedelic drugs,” saying “in many cases, these experimental treatments have shown life-changing potential for those suffering from severe mental illness and depression, including our cherished veterans.”

Trump said he ordered his deputies to pursue fast-tracking after receiving information from “the great Joe Rogan” and others. Rogan noted he texted Trump about ibogaine and studies showing over 80 percent of people addicted to opioids who take one dose of ibogaine “are free of that addiction.” “I sent him that information. The text message that came back: ‘Sounds great. Do you want FDA approval? Let’s do it.’ Literally that quick,” Rogan said.

Trump instructed Health and Human Services Secretary Robert F. Kennedy Jr., Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz, FDA Commissioner Marty Makary, and National Institutes of Health Director Jay Bhattacharya to pursue the initiative. “It was uniform support, and I said, ‘So why would we wait three or four years to get it done or ten years, frankly? Let’s get it done immediately.’ And that’s what happened,” Trump said. Rogan commented on the historical context of psychedelic prohibition, arguing the Controlled Substances Act of 1970 was “meant to target” the Civil Rights and anti-war movements rather than address inherent drug harm.


This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://us.headtopics.com/news/joe-rogan-joins-trump-for-signing-of-eo-to-fast-track-82387617